Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

AAPK-25

Catalog No. T10215Cas No. 2247919-28-2

AAPK-25 is a potent and selective Aurora/PLK dual inhibitor with anti-tumor activity, causing mitotic delay and arresting cells in prometaphase, followed by increased apoptosis. It targets Aurora-A/-B/-C with Kd values ranging from 23-289 nM.

AAPK-25

AAPK-25

Purity: 97.79%
Catalog No. T10215Cas No. 2247919-28-2
AAPK-25 is a potent and selective Aurora/PLK dual inhibitor with anti-tumor activity, causing mitotic delay and arresting cells in prometaphase, followed by increased apoptosis. It targets Aurora-A/-B/-C with Kd values ranging from 23-289 nM.
Pack SizePriceAvailabilityQuantity
1 mg$87In Stock
5 mg$212In Stock
10 mg$318In Stock
25 mg$579In Stock
50 mg$868In Stock
100 mg$1,260In Stock
1 mL x 10 mM (in DMSO)$245In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "AAPK-25"

Select Batch
Purity:97.79%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
AAPK-25 is a potent and selective Aurora/PLK dual inhibitor with anti-tumor activity, causing mitotic delay and arresting cells in prometaphase, followed by increased apoptosis. It targets Aurora-A/-B/-C with Kd values ranging from 23-289 nM.
Targets&IC50
PLK1:55 nM (kd), CDK:8.02 μM , Aurora C:289 nM (kd), ERK:5.32 μM (kd), Aurora A:23 nM (kd), PLK3:456 nM (kd), Aurora B:78 nM (kd), PLK2:272 nM (kd), PI3K:7.11 μM (kd)
In vitro
AAPK-25 inhibits the growth of HCT-116, Calu6, A549, and MCF-7 cells (IC50s: 0.4, 5.3, 11.6, and 2.3 μM). It induces apoptosis in a dose-dependent manner in the HCT-116 cell line, significantly increases histone H3Ser10 phosphorylation, indicating a marked mitotic block, and notably inhibits the mitotic spindle checkpoint.
In vivo
AAPK-25 enhances the survival rate in the BALB/c nude mice tumor xenograft model.
Chemical Properties
Molecular Weight442.32
FormulaC21H13Cl2N3O2S
Cas No.2247919-28-2
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 50 mg/mL (113.04 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.2608 mL11.3040 mL22.6081 mL113.0403 mL
5 mM0.4522 mL2.2608 mL4.5216 mL22.6081 mL
10 mM0.2261 mL1.1304 mL2.2608 mL11.3040 mL
20 mM0.1130 mL0.5652 mL1.1304 mL5.6520 mL
50 mM0.0452 mL0.2261 mL0.4522 mL2.2608 mL
100 mM0.0226 mL0.1130 mL0.2261 mL1.1304 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy AAPK-25 | purchase AAPK-25 | AAPK-25 cost | order AAPK-25 | AAPK-25 chemical structure | AAPK-25 in vivo | AAPK-25 in vitro | AAPK-25 formula | AAPK-25 molecular weight